In a filing, Syros Pharmaceuticals Inc revealed its Chief Development Officer Stephens Kristin unloaded Company’s shares for reported $7949.0 on Nov 18 ’24. In the deal valued at $0.22 per share,36,133 shares were sold. As a result of this transaction, Stephens Kristin now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Roth David sold 12,099 shares, generating $2,382 in total proceeds. Upon selling the shares at $0.20, the Chief Medical Officer now owns 0 shares.
Before that, Quirk Gerald E sold 46,657 shares. Syros Pharmaceuticals Inc shares valued at $10,321 were divested by the Chief Legal & Compliance Offic at a price of $0.22 per share. As a result of the transaction, Quirk Gerald E now holds 0 shares, worth roughly $0.0.
H.C. Wainwright upgraded its Syros Pharmaceuticals Inc [SYRS] rating to a Buy from a a Neutral in a research note published on November 04, 2020; the price target was increased to $15 from $11. A number of analysts have revised their coverage, including Alliance Global Partners’s analysts, who began to cover the stock in late September with a ‘”a Buy”‘ rating. Wedbush also remained covering SYRS and has decreased its forecast on January 17, 2020 with a “Neutral” recommendation from previously “an Outperform” rating.
Price Performance Review of SYRS
On Friday, Syros Pharmaceuticals Inc [NASDAQ:SYRS] saw its stock jump 12.77% to $0.29. Over the last five days, the stock has gained 13.07%. Syros Pharmaceuticals Inc shares have fallen nearly -96.24% since the year began. Nevertheless, the stocks have fallen -89.14% over the past one year. While a 52-week high of $8.17 was reached on 01/02/24, a 52-week low of $0.18 was recorded on 11/18/24. SMA at 50 days reached $1.8547, while 200 days put it at $4.3116.
Levels Of Support And Resistance For SYRS Stock
The 24-hour chart illustrates a support level at 0.2678, which if violated will result in even more drops to 0.2423. On the upside, there is a resistance level at 0.3085. A further resistance level may holdings at 0.3237. The Relative Strength Index (RSI) on the 14-day chart is 29.47, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.0277, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.57%. Stochastics %K at 3.05% indicates the stock is a buying.
How much short interest is there in Syros Pharmaceuticals Inc?
A steep rise in short interest was recorded in Syros Pharmaceuticals Inc stocks on 2024-10-31, growing by 0.25 million shares to a total of 1.25 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 1.0 million shares. There was a rise of 19.91%, which implies that there is a positive sentiment for the stock.
